...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Voting Results

Has anybody seen the voting results for ZCC sent in prior to the AGM?

Toinv

Share
New Message
Please login to post a reply